Discover / Filter / Explore
Stock screener
Find the businesses that fit your questions.
| Ticker | Company | Revenue | Net income | Net margin ▴ | Return on equity | Revenue growth | Diluted EPS |
|---|---|---|---|---|---|---|---|
| RXRX | Manufacturing · Year ended 2025-12-31 · USD | $74.68M | -$644.76M | -863.4% | -57.0% | 26.9% | -$1.44 |
| KYMR | Manufacturing · Year ended 2025-12-31 · USD | $39.21M | -$311.35M | -794.0% | -19.7% | -16.7% | -$3.69 |
| ALEC | Manufacturing · Year ended 2025-12-31 · USD | $21.05M | -$142.93M | -679.2% | -466.3% | -79.1% | -$1.39 |
| VIR | Manufacturing · Year ended 2025-12-31 · USD | $68.56M | -$437.99M | -638.9% | -57.2% | -7.6% | -$3.16 |
| SCNI | Manufacturing · Year ended 2025-12-31 · USD | $1.31M | -$8.31M | -633.6% | -102.5% | 99.2% | n/a |
| LCTX | Manufacturing · Year ended 2025-12-31 · USD | $14.56M | -$63.53M | -436.5% | -146.6% | 53.2% | -$0.28 |
| LENZ | Manufacturing · Year ended 2025-12-31 · USD | $19.09M | -$82.13M | -430.3% | -28.9% | n/a | -$2.85 |
| EDIT | Manufacturing · Year ended 2025-12-31 · USD | $40.52M | -$160.06M | -395.0% | -586.6% | 25.4% | -$1.80 |
| AUTL | Manufacturing · Year ended 2025-12-31 · USD | $75.39M | -$287.53M | -381.4% | -161.4% | 644.9% | -$1.08 |
| MGX | Manufacturing · Year ended 2025-12-31 · USD | $25.21M | -$87.87M | -348.5% | -55.4% | -51.8% | -$2.36 |
| SGMOQ | Manufacturing · Year ended 2025-12-31 · USD | $39.55M | -$122.93M | -310.8% | n/a | -31.6% | -$0.44 |
| IBRX | Manufacturing · Year ended 2025-12-31 · USD | $113.29M | -$351.40M | -310.2% | n/a | 668.3% | -$0.38 |
| VYGR | Manufacturing · Year ended 2025-12-31 · USD | $40.37M | -$119.72M | -296.5% | -61.1% | -49.5% | -$2.04 |
| CCCC | Manufacturing · Year ended 2025-12-31 · USD | $35.95M | -$104.99M | -292.1% | -40.9% | 1.0% | -$1.27 |
| PTHS | Manufacturing · Year ended 2025-12-31 · USD | $16.80M | -$43.32M | -257.9% | -111.4% | n/a | -$23.04 |
| DYAI | Manufacturing · Year ended 2025-12-31 · USD | $3.09M | -$7.36M | -238.3% | -597.6% | -11.6% | -$0.23 |
| XFOR | Manufacturing · Year ended 2025-12-31 · USD | $35.11M | -$79.20M | -225.6% | -42.5% | n/m | -$1.87 |
| ACOG | Manufacturing · Year ended 2025-12-31 · USD | $10.22M | -$20.67M | -202.2% | -33.1% | n/a | -$1.18 |
| STRO | Manufacturing · Year ended 2025-12-31 · USD | $102.48M | -$191.09M | -186.5% | n/a | 65.2% | -$22.49 |
| DNA | Manufacturing · Year ended 2025-12-31 · USD | $170.16M | -$312.76M | -183.8% | -61.5% | -25.1% | -$5.64 |
| FDMT | Manufacturing · Year ended 2025-12-31 · USD | $85.21M | -$140.11M | -164.4% | -27.7% | n/m | -$2.42 |
| IOVA | Manufacturing · Year ended 2025-12-31 · USD | $263.50M | -$390.98M | -148.4% | -56.0% | 60.6% | -$1.09 |
| MRNA | Manufacturing · Year ended 2025-12-31 · USD | $1.94B | -$2.82B | -145.2% | -32.6% | -39.9% | -$7.26 |
| MGTX | Manufacturing · Year ended 2025-12-31 · USD | $81.39M | -$114.20M | -140.3% | n/a | 144.6% | -$1.42 |
| DTIL | Manufacturing · Year ended 2025-12-31 · USD | $34.26M | -$45.72M | -133.4% | -49.6% | -50.1% | -$3.56 |